Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2013; 19(20): 3083-3089
Published online May 28, 2013. doi: 10.3748/wjg.v19.i20.3083
Published online May 28, 2013. doi: 10.3748/wjg.v19.i20.3083
Table 2 Patients' model for end-stage liver disease and Child-Pugh scores
| HIFU (n = 10) | TACE (n = 29) | |
| MELD score (P = 0.687) | ||
| 14 | 0 | 2 |
| 13 | 1 | 4 |
| 12 | 1 | 4 |
| 11 | 4 | 7 |
| 10 | 1 | 3 |
| 9 | 1 | 3 |
| 8 | 0 | 1 |
| 7 | 1 | 4 |
| 6 | 1 | 1 |
| Child-Pugh score (P = 0.096) | ||
| 5 | 0 | 10 |
| 6 | 3 | 7 |
| 7 | 5 | 4 |
| 8 | 1 | 5 |
| 9 | 0 | 2 |
| 10 | 1 | 1 |
- Citation: Cheung TT, Fan ST, Chan SC, Chok KS, Chu FS, Jenkins CR, Lo RC, Fung JY, Chan AC, Sharr WW, Tsang SH, Dai WC, Poon RT, Lo CM. High-intensity focused ultrasound ablation: An effective bridging therapy for hepatocellular carcinoma patients. World J Gastroenterol 2013; 19(20): 3083-3089
- URL: https://www.wjgnet.com/1007-9327/full/v19/i20/3083.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i20.3083